function confirmModerate(url,num,pid){ url = url + '?Comments[do]=mod&Comments[pid]=' + pid + '&Comments[id]=' + num + '#Comments_' + num; if (confirm('Do you want to report this comment as inappropriate?')) location.href=url; return 0; } function validate_form(frm) { var value = ''; var errFlag = new Array(); _qfMsg = ''; value = frm.elements['Comments[name]'].value; if (value == '' && !errFlag['name']) { errFlag['name'] = true; _qfMsg = _qfMsg + '\n - Please enter your name'; } value = frm.elements['Comments[captcha]'].value; if (value == '' && !errFlag['captcha']) { errFlag['captcha'] = true; _qfMsg = _qfMsg + '\n - Please enter Security Code'; } value = frm.elements['Comments[mail]'].value; if (value == '' && !errFlag['mail']) { errFlag['mail'] = true; _qfMsg = _qfMsg + '\n - Please enter your e-mail'; } var regex = /^((\"[^\"\f\n\r\t\v\b]+\")|([\w\!\#\$\%\&'\*\+\-\~\/\^\`\|\{\}]+(\.[\w\!\#\$\%\&'\*\+\-\~\/\^\`\|\{\}]+)*))@((\[(((25[0-5])|(2[0-4][0-9])|([0-1]?[0-9]?[0-9]))\.((25[0-5])|(2[0-4][0-9])|([0-1]?[0-9]?[0-9]))\.((25[0-5])|(2[0-4][0-9])|([0-1]?[0-9]?[0-9]))\.((25[0-5])|(2[0-4][0-9])|([0-1]?[0-9]?[0-9])))\])|(((25[0-5])|(2[0-4][0-9])|([0-1]?[0-9]?[0-9]))\.((25[0-5])|(2[0-4][0-9])|([0-1]?[0-9]?[0-9]))\.((25[0-5])|(2[0-4][0-9])|([0-1]?[0-9]?[0-9]))\.((25[0-5])|(2[0-4][0-9])|([0-1]?[0-9]?[0-9])))|((([A-Za-z0-9\-])+\.)+[A-Za-z\-]+))$/; if (value != '' &&!regex.test(value) && !errFlag['mail']) { errFlag['mail'] = true; _qfMsg = _qfMsg + '\n - E-mail address format is invalid'; } value = frm.elements['Comments[text]'].value; if (value == '' && !errFlag['text']) { errFlag['text'] = true; _qfMsg = _qfMsg + '\n - Please enter your comment'; } if (value.length<50 && !errFlag['text']) { errFlag['text'] = true; _qfMsg = _qfMsg + '\n - Comment is too short (50 characters min.)'; } if (value.length>4000 && !errFlag['text']) { errFlag['text'] = true; _qfMsg = _qfMsg + '\n - Comment is too long (4000 characters max)'; } if (_qfMsg != '') { _qfMsg = 'Invalid information entered:' + _qfMsg + '\nPlease correct these fields.'; alert(_qfMsg); return false; } return true; } //]]>

FRANCE: MANAGEMENT SHUFFLE AT AVENTIS PHARMA

Article Abstract:

Aventis Pharma has set up a Board of directors composed of Daniel Camus, Frank L. Douglas, Bernard Dubois, Guy Ivol, Dirk Oldenburg, and Thierry Soursac, while the supervisory board, managed by Gilles Brisson with Olivier Jacquesson as vice president, includes Alain Chevallier, Dominique Even, and Francois Meyer as MDs. Aventis Pharma is based in Antony , the same as Aventis Pharma Specialites which named Bernard Baudrand as joint manager.

Publisher: Revue Hebdomadaire
Publication Name: Revue Hebdomadaire des Industries Chimiques
Subject: Chemicals, plastics and rubber industries
ISSN:
Year: 2001

User Contributions:

Comment about this article or add new information about this topic:

FRANCE: FREDERICO ANTON MENCIA HEADS PHARMAFARM

Article Abstract:

Frederico Anton Mencia has become president of Laboratoires Pharmafarm, which has an equity of EUR 5.4mn and which is located in the 16th arrondissement of Paris. He replaces Gilles de Suyrot.

Publisher: Revue Hebdomadaire
Publication Name: Revue Hebdomadaire des Industries Chimiques
Subject: Chemicals, plastics and rubber industries
ISSN:
Year: 2001

User Contributions:

Comment about this article or add new information about this topic:

Subjects list: Drugs, France

Similar abstracts:

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.